Keyphrases
Lung Disease
100%
Respiratory Syncytial Virus Infection
100%
Hypoxia-inducible Factor
100%
Hypoxia-inducible factor-1α (HIF-1α)
66%
Respiratory Syncytial Virus
50%
Airway Function
33%
Hypoxia-inducible Factor 2
33%
T Cells
16%
Virus
16%
Viral Replication
16%
In Vitro Study
16%
Transcription Factor
16%
Lung
16%
Virus Replication
16%
Non-infectious
16%
Clinical Disease
16%
Balb C Mice
16%
Viral Titer
16%
Respiratory Viruses
16%
Clinical Parameters
16%
Hypoxia Inhibitors
16%
Antiviral Strategy
16%
Infection Model
16%
Lung Pathology
16%
Cellular Compartments
16%
Lung Cells
16%
Normoxic Conditions
16%
Low Oxygen
16%
Therapeutic Considerations
16%
Disease Parameters
16%
Antiviral Potential
16%
PT2385
16%
Pharmacology, Toxicology and Pharmaceutical Science
Respiratory Syncytial Virus Infection
100%
Lung Disease
100%
Hypoxia Inducible Factor
100%
Hypoxia Inducible Factor 1
44%
Human Respiratory Syncytial Virus
33%
Antivirus Agent
22%
Prothrombin
22%
Diseases
22%
Infection
11%
Transcription Factors
11%
Bagg Albino Mouse
11%
Respiratory Virus
11%
4 [bis(2 Chloroethyl)oxidoamino]phenylalanine
11%
Immunology and Microbiology
Respiratory Syncytial Virus Infection
100%
Hypoxia Inducible Factor
100%
Hypoxia Inducible Factor 1
44%
Human Respiratory Syncytial Virus
33%
Airway
22%
T Cell
11%
Viral Replication
11%
Transcription Factors
11%
Bagg Albino Mouse
11%
Viral Replication
11%
Viral Load
11%
Respiratory Virus
11%
Virus
11%
Replication
11%
Infection
11%
In Vitro
11%